Lead optimization screening assays for admet and safety profiling
Ended Awarded Last action
- Contract number
- 75N93021F00003
- Awardee
-
Eurofins Discovery Services North America, LLC UEI HF4LCAU68M93
- Awarding agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Obligated
- $220,022
Award facts
- Contract value 52% obligated
-
- $220,022.00 Current, with exercised options
- $427,066.00 Potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 541714 Research and Development in Biotechnology (except Nanobiotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Multiple Award, Fair Opportunity
- Pricing
- Firm Fixed Price
- Place of performance
- Weldon Spring, MO 63304, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Funding Only Action | -$43,956 | |
| Other Administrative Action | $0 | |
| Original award | $263,978 |
About this award
The National Institute of Allergy and Infectious Diseases issued a $427,066 delivery order to Eurofins Discovery Services North America, LLC on August 31, 2021, under the Nonclinical Services for Development of Interventional Agents parent IDIQ for lead optimization screening assays for ADMET and safety profiling.
Place of performance is Weldon Spring, Missouri. The order was firm fixed price with an ultimate completion date of August 30, 2022. The award was issued to de-obligate unexpended and expiring fiscal year 2021 funding in accordance with 31 U.S.C. Section 1552(a) in preparation for the September 30, 2026 closing of the period of availability of those funds.
Quick answers
Who was awarded contract 75N93021F00003?
75N93021F00003 was awarded to Eurofins Discovery Services North America, LLC by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 31, 2021.
How much is contract 75N93021F00003 worth?
The government has obligated $220,022 on 75N93021F00003. Its potential value, with all options, is $427,066.
Is contract 75N93021F00003 an order under another contract?
Yes. 75N93021F00003 is a delivery order under 75N93018D00007, an indefinite delivery contract, on Nonclinical Services for Development of Interventional Agents.
Was contract 75N93021F00003 competed?
The extent of competition for 75N93021F00003 was full and open competition. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award